Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | PI4KA | P42356 | 6/20 | 0.41 |
| ▸ | PI4K2B | Q8TCG2 | 6/20 | 0.41 |
| ▸ | PI4K2A | Q9BTU6 | 6/20 | 0.41 |
| ▸ | PI4KB | Q9UBF8 | 6/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 3/20 | 0.41 |
| ▸ | XDH | P47989 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.38 |
| ▸ | RET | P07949 | 2/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29385750 | 1.00 | ERAP1 (0.61) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL1002106 | 0.77 | ACHE (0.42) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL12779523 | 0.77 | GDA (0.42) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL13354614 | 0.77 | GDA (0.47) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL4745018 | 0.76 | ERAP1 (1.00) | ERAP1MAPTADORA2AADORA1PI4KA | |
| SCHEMBL30526467 | 0.76 | ERAP1 (1.00) | ERAP1MAPTADORA2AADORA1PI4KA | |
| SCHEMBL38855 | 0.74 | PDPK1 (0.42) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL2398078 | 0.72 | SLC6A5 (0.44) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL6746072 | 0.72 | LRRK2 (0.44) | ERAP1ACHEGDAMAPTSLC6A5 | |
| SCHEMBL10217112 | 0.72 | FFAR2 (0.40) | ERAP1ACHEGDAMAPTSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2261 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630851-B2 | Polynucleotide modification methods | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-05-19 | — | — | US | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260027237-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR ADAR-MEDIATED RNA EDITING | PROQR THERAPEUTICS II B.V. (NL) | 2026-01-29 | — | — | US | claimed |
| EP-4605531-A1 | HETERODUPLEX RNA EDITING OLIGONUCLEOTIDE COMPLEXES | ProQR Therapeutics II B.V. (NL) | 2025-08-27 | — | — | EP | claimed |
| WO-2025111452-A2 | CHEMICAL MODIFICATIONS IN PEgRNA and ngRNAs | PRIME MEDICINE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2025111430-A1 | CHEMICAL MODIFICATIONS IN mRNA POLY(A) TAIL | PRIME MEDICINE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-4555085-A1 | CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR ADAR-MEDIATED RNA EDITING | ProQR Therapeutics II B.V. (NL) | 2025-05-21 | — | — | EP | claimed |
| WO-2025080869-A1 | PANCREATIC CANCER IMMUNOTHERAPY USING CATIONIC LIPID AND POLYMER NANOCARRIERS FOR CO-DELIVERY OF KRAS NEOANTIGENS AND STING AND/OR OTHER IMMUNOMODULATORS TO BOOST THE CANCER IMMUNITY CYCLE AND TREAT LIVER METASTASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-17 | — | — | WO | claimed |
| WO-2003023365-A2 | ELECTROCHEMICAL SENSOR USING INTERCALATIVE, REDOX-ACTIVE MOIETIES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-03-20 | — | — | WO | claimed |
| US-20020146716-A1 | Electrochemical sensor using intercalative, redox-active moieties | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-10-10 | — | — | US | claimed |
| US-6361951-B1 | MIXING DNA SAMPLE WITH AN OLIGONUCLEOTIDE PROBE, FORMING A HYBRIDIZATION COMPLEX THAT IS REACTED WITH A TRANSITION METAL COMPLEX CAPABLE OF OXIDIZING A PRESELECTED NUCLEOTIDE BASE OF THE OLIGONUCLEOTIDE PROBE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2002-03-26 | — | — | US | claimed |
| US-6309825-B1 | Analytical and therapeutic agents | UNIVERSITY OF LEICESTER (GB) | 2001-10-30 | — | — | US | claimed |
| EP-0828854-B1 | ANALYTICAL AND THERAPEUTIC AGENTS | UNIV LEICESTER (GB) | 2000-05-31 | — | — | EP | claimed |
| EP-0828854-A1 | ANALYTICAL AND THERAPEUTIC AGENTS | UNIVERSITY OF LEICESTER (GB) | 1998-03-18 | — | — | EP | claimed |
| US-5665541-A | Formation of triple helix complexes for the detection of double stranded DNA sequences using oligomers which comprise an 8-modified purine base | THE JOHNS HOPKINS UNIVERSITY (US) | 1997-09-09 | — | — | US | claimed |
| WO-1996038588-A1 | ANALYTICAL AND THERAPEUTIC AGENTS | UNIVERSITY OF LEICESTER (GB) | 1996-12-05 | — | — | WO | claimed |
| EP-0672171-A1 | FORMATION OF TRIPLE HELIX COMPLEXES OF DOUBLE STRANDED DNA USING NUCLEOSIDE OLIGOMERS WHICH COMPRISE PURINE BASE ANALOGS | THE JOHNS HOPKINS UNIVERSITY (US) | 1995-09-20 | — | — | EP | claimed |
| WO-1993005180-A1 | FORMATION OF TRIPLE HELIX COMPLEXES OF DOUBLE STRANDED DNA USING NUCLEOSIDE OLIGOMERS WHICH COMPRISE PURINE BASE ANALOGS | THE JOHNS HOPKINS UNIVERSITY (US) | 1993-03-18 | — | — | WO | claimed |